{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:06:47Z","timestamp":1791104807677,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.revmed.2013.02.030","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T15:49:07Z","timestamp":1363880947000},"page":"421-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Manifestations ophtalmologiques de la maladie de Horton"],"prefix":"10.1016","volume":"34","author":[{"given":"E.","family":"Liozon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.-H.","family":"Ly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-Y.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.02.030_bib0005","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0950-3579(05)80064-0","article-title":"Ophthalmic features of giant cell arteritis","volume":"5","author":"Hayreh","year":"1991","journal-title":"Bailleres Clin Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0015","first-page":"249","article-title":"The ocular lesions of temporal arteritis","volume":"55","author":"Wagener","year":"1957","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.revmed.2013.02.030_bib0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1212\/WNL.10.5.490","article-title":"Neurologic aspects of temporal arteritis","volume":"10","author":"Hollenhorst","year":"1960","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bjo.47.9.555","article-title":"Temporal arteritis","volume":"47","author":"Whitfield","year":"1963","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0030","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0035","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161\u00a0patients","volume":"79","author":"Gonzalez-Gay","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2013.02.030_bib0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174\u00a0patients","volume":"111","author":"Liozon","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2013.02.030_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/rheumatology\/36.2.251","article-title":"Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis","volume":"36","author":"Font","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/01.md.0000119761.27564.c9","article-title":"Risk factors for cranial ischemic complications in giant cell arteritis","volume":"83","author":"Nesher","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2013.02.030_bib0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/art.21075","article-title":"Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0065","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.22141","article-title":"Antiplatelet and anticoagulant therapy in patients with giant cell arteritis","volume":"54","author":"Lee","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/ken480","article-title":"High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition","volume":"48","author":"Berger","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0075","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.38.3.352","article-title":"Neurologic disease in biopsy-proven giant cell (temporal) arteritis","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","article-title":"Ocular manifestations of giant cell arteritis","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/md.0b013e31803d1764","article-title":"Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study","volume":"86","author":"Gonzalez-Gay","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2013.02.030_bib0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archopht.1962.00960030012004","article-title":"Occult temporal arteritis","volume":"68","author":"Simons","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0095","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9394(99)80193-7","article-title":"Occult giant cell arteritis: ocular manifestations","volume":"125","author":"Hayreh","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.282.6260.269","article-title":"Prognosis in giant-cell arteritis","volume":"282","author":"Graham","year":"1981","journal-title":"Br Med J"},{"key":"10.1016\/j.revmed.2013.02.030_bib0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/rheumatology\/ken515","article-title":"Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis?","volume":"48","author":"Schmidt","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0161-6420(02)01775-X","article-title":"Recovery of visual function in patients with biopsy-proven giant cell arteritis","volume":"110","author":"Foroozan","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02150450","article-title":"Reversible choroidal vascular insufficiency without infarction in temporal arteritis","volume":"218","author":"Fastenberg","year":"1982","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/0301-4738.77024","article-title":"Management of ischemic optic neuropathies","volume":"59","author":"Hayreh","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/eye.1990.4","article-title":"Anterior ischaemic optic neuropathy. differentiation of arteritic from non-arteritic type and its management","volume":"4","author":"Hayreh","year":"1990","journal-title":"Eye"},{"key":"10.1016\/j.revmed.2013.02.030_bib0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.preteyeres.2008.11.002","article-title":"Ischemic optic neuropathy","volume":"28","author":"Hayreh","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.revmed.2013.02.030_bib0135","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0420.2002.800403.x","article-title":"Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature","volume":"80","author":"Hayreh","year":"2002","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.revmed.2013.02.030_bib0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00041327-200503000-00004","article-title":"Predictors of recurrent ischemic optic neuropathy in giant cell arteritis","volume":"25","author":"Chan","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0150","first-page":"693","article-title":"Internuclear ophthalmoplegia in giant cell arteritis","volume":"16","author":"Thomson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jnnp.55.1.84-b","article-title":"Internuclear ophthalmoplegia in giant cell arteritis","volume":"55","author":"Johnston","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2013.02.030_bib0160","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/jnnp.57.6.764","article-title":"Cervical radiculopathy and bilateral internuclear ophthalmoplegia caused by temporal arteritis","volume":"57","author":"Hughes","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2013.02.030_bib0165","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jama.287.1.92","article-title":"Does this patient have temporal arteritis?","volume":"287","author":"Smetana","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2013.02.030_bib0170","first-page":"1","article-title":"Giant cell arteritis","volume":"658","author":"Bengtsson","year":"1982","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.revmed.2013.02.030_bib0175","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.revmed.2010.12.014","article-title":"Hallucinations visuelles et maladie de Horton\u00a0: \u00e0 propos du syndrome de Charles Bonnet","volume":"32","author":"Bloch","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.02.030_bib0180","first-page":"1596","article-title":"Charles Bonnet syndrome in temporal arteritis","volume":"22","author":"Sonnenblick","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1176\/jnp.16.4.505","article-title":"Steroid-responsive Charles Bonnet syndrome in temporal arteritis","volume":"16","author":"Razavi","year":"2004","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.revmed.2013.02.030_bib0190","first-page":"587","article-title":"Orbital pseudo-tumor in temporal arteritis revealed by computerized tomography","volume":"8","author":"Chertok","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s004170100310","article-title":"Orbital presentations of giant cell arteritis","volume":"239","author":"Lee","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0200","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.59.6.332","article-title":"Cortical blindness in cranial arteritis","volume":"59","author":"Chisholm","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0205","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3129\/i07-068","article-title":"Giant cell arteritis presenting with hemianopic visual field loss","volume":"42","author":"Randhawa","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/bjo.68.2.135","article-title":"Tonic pupil with giant cell arteritis","volume":"68","author":"Currie","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0215","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/bjo.87.4.510","article-title":"Tonic pupils from giant cell arteritis","volume":"87","author":"Foroozan","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0220","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jns.2009.04.027","article-title":"Mydriatic pupil in giant cell arteritis","volume":"284","author":"Prasad","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.revmed.2013.02.030_bib0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0248-8663(03)00116-4","article-title":"Une isch\u00e9mie du segment ant\u00e9rieur de l\u2019\u0153il","volume":"24","author":"V\u00e9drine","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.02.030_bib0230","first-page":"233","article-title":"Ocular ichemia syndrome: a malignant course of giant cell arteritis","volume":"10","author":"Schmidt","year":"2005","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.revmed.2013.02.030_bib0235","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0002-9394(14)74798-1","article-title":"Giant cell arteritis in the ocular ischemic syndrome","volume":"113","author":"Hamed","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0240","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(98)00313-4","article-title":"Bilateral ocular ischemic syndrome secondary to giant cell arteritis progressing despite corticosteroid treatment","volume":"127","author":"Hwang","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0245","first-page":"306","article-title":"Bilateral ocular ischemic syndrome secondary to giant cell arteritis","volume":"119","author":"Casson","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0250","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/bjo.84.3.337d","article-title":"Panuveitis as a presenting feature of giant cell arteritis","volume":"84","author":"Rajesh","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0255","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/bjo.53.11.721","article-title":"Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc","volume":"53","author":"Hayreh","year":"1969","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0260","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9394(70)91859-3","article-title":"Histopathology of ischemic optic neuropathy","volume":"69","author":"Henkind","year":"1970","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0265","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.1972.00490170010003","article-title":"Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement","volume":"27","author":"Wilkinson","year":"1972","journal-title":"Arch Neurol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0270","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0039-6257(76)90224-1","article-title":"Ophthalmic complications of giant cell arteritis","volume":"20","author":"Cullen","year":"1976","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0275","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/brain\/100.2.209","article-title":"Ophthalmoplegia in cranial arteritis","volume":"100","author":"Barricks","year":"1977","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2013.02.030_bib0280","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/bjo.57.10.766","article-title":"Blood vessels of the ciliary ganglion in man","volume":"57","author":"Eliskova","year":"1973","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0285","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.wno.0000249332.95722.22","article-title":"Intraocular pressure is low in eyes with giant cell arteritis","volume":"26","author":"Huna-Baron","year":"2006","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0290","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/bjo.58.12.964","article-title":"Anterior ischaemic optic neuropathy. II. Fundus on ophthalmoscopy and fluorescein angiography","volume":"58","author":"Hayreh","year":"1974","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9394(14)73525-1","article-title":"Fluoresceine angiography in the diagnosis of giant cell arteritis","volume":"115","author":"Siatkowski","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0300","first-page":"221","article-title":"Delayed choroidal perfusion in giant cell arteritis","volume":"11","author":"Mack","year":"1991","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9394(14)73018-1","article-title":"Visual loss caused by choroidal ischemia preceding anterior ischemic optic neuropathy in giant cell arteritis","volume":"117","author":"Slavin","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0310","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0161-6420(95)30820-2","article-title":"Cotton-wool spots and the early diagnosis of giant cell arteritis","volume":"102","author":"Melberg","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0315","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archopht.124.6.922","article-title":"Bilateral choroidal ischemia in giant cell arteritis","volume":"124","author":"Cohen","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0320","first-page":"122","article-title":"La maladie de Horton","volume":"140","author":"Liozon","year":"1989","journal-title":"Ann Med Interne"},{"issue":"Suppl. C","key":"10.1016\/j.revmed.2013.02.030_bib0325","first-page":"116","article-title":"Int\u00e9r\u00eat du Doppler art\u00e9riel dans la maladie de Horton. \u00c9tude prospective de 59\u00a0observations","volume":"14","author":"Vinckier","year":"1989","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.revmed.2013.02.030_bib0330","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archopht.1994.01090190086026","article-title":"Color Doppler hemodynamics of giant cell arteritis","volume":"112","author":"Ho","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"Pt 4","key":"10.1016\/j.revmed.2013.02.030_bib0335","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/eye.1996.101","article-title":"Colour Doppler imaging in giant cell (temporal) arteritis: serial examination and comparison with non-arteritic anterior ischaemic optic neuropathy","volume":"10","author":"Ghanchi","year":"1996","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.revmed.2013.02.030_bib0340","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00041327-199912000-00005","article-title":"Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy","volume":"19","author":"Lee","year":"1999","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0345","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/art.21089","article-title":"Magnetic resonance imaging in optic neuritis due to giant cell arteritis","volume":"53","author":"Garcia-Porrua","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0350","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/rheumatology\/kep011","article-title":"Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI","volume":"48","author":"Geiger","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0355","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/112067210401400310","article-title":"Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy","volume":"14","author":"Costello","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0360","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/rheumatology\/ker265","article-title":"Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors","volume":"50","author":"Mackie","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0365","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0370","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240\u00a0patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2013.02.030_bib0375","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.md.0000180043.19285.54","article-title":"Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240\u00a0patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2013.02.030_bib0380","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semarthrit.2007.10.014","article-title":"The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis","volume":"38","author":"Lopez-Diaz","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0385","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1034\/j.1600-0579.2003.00223.x","article-title":"Visual prognosis in extremely old patients with temporal (giant cell) arteritis","volume":"51","author":"Liozon","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.revmed.2013.02.030_bib0390","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/jnnp.2006.113787","article-title":"Risk factors for early visual deterioration in temporal arteritis","volume":"78","author":"Loddenkemper","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2013.02.030_bib0395","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0248-8663(05)82862-0","article-title":"Le retard diagnostique dans la maladie de Horton. Analyse du d\u00e9lai diagnostique \u00e0 partir d\u2019une \u00e9tude r\u00e9trospective de 130\u00a0cas","volume":"12","author":"Kelkel","year":"1991","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.02.030_bib0400","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10067-010-1616-y","article-title":"Delays in recognition and management of giant cell arteritis: results from a retrospective audit","volume":"30","author":"Ezeonyeji","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0405","first-page":"1272","article-title":"Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course","volume":"30","author":"Liozon","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0410","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MD.0b013e318145275c","article-title":"Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100\u00a0patients","volume":"86","author":"Hernandez-Rodriguez","year":"2007","journal-title":"Medicine"},{"issue":"Suppl. C","key":"10.1016\/j.revmed.2013.02.030_bib0415","first-page":"109","article-title":"R\u00f4le du Doppler dans le diagnostic des complications ophtalmologiques de la maladie de Horton","volume":"14","author":"Dany","year":"1989","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.revmed.2013.02.030_bib0420","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.58.6.335","article-title":"Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease","volume":"58","author":"Duhaut","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.02.030_bib0425","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6","article-title":"Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis","volume":"41","author":"Kaiser","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0430","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/rheumatology\/ken012","article-title":"Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis?","volume":"47","author":"Makkuni","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0435","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.084947","article-title":"Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss","volume":"68","author":"Chatelain","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.02.030_bib0440","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10067-006-0332-0","article-title":"Relationship between histological subtypes and clinical characteristics at presentation and outcome in biopsy-proven temporal arteritis. Identification of a relatively benign subgroup","volume":"26","author":"Borg","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0445","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.57.6.380","article-title":"Relation between HLA DRB1\u00a0alleles and corticosteroid resistance in giant cell arteritis","volume":"57","author":"Rauzy","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2013.02.030_bib0450","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/art.10071","article-title":"Therapeutic effects of acetylsalicylic acid in giant cell arteritis","volume":"46","author":"Weyand","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0455","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","article-title":"Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis","volume":"50","author":"Nesher","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 49","key":"10.1016\/j.revmed.2013.02.030_bib0460","first-page":"S57","article-title":"Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis","volume":"26","author":"Narvaez","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0465","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MD.0b013e31821c4fad","article-title":"Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain","volume":"90","author":"Martinez-Lado","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2013.02.030_bib0470","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000070631","article-title":"Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies","volume":"217","author":"Hayreh","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.revmed.2013.02.030_bib0475","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"International Network for the Study of Systemic Vasculitides. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0480","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MD.0b013e3181af4518","article-title":"Strokes at time of disease diagnosis in a series of 287\u00a0patients with biopsy-proven giant cell arteritis","volume":"88","author":"Gonzalez-Gay","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2013.02.030_bib0485","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)02210-8","article-title":"Steroid therapy for visual loss in patients with giant cell arteritis","volume":"355","author":"Hayreh","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2013.02.030_bib0490","first-page":"140","article-title":"The treatment of giant cell arteritis","volume":"5","author":"Fraser","year":"2008","journal-title":"Rev Neurol Dis"},{"key":"10.1016\/j.revmed.2013.02.030_bib0495","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0755-4982(04)98475-8","article-title":"La maladie de Horton compliqu\u00e9e\u00a0: modalit\u00e9s th\u00e9rapeutiques","volume":"33","author":"Agard","year":"2004","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2013.02.030_bib0500","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0002-9343(86)90066-5","article-title":"Treatment of temporal arteritis with ocular involvement","volume":"80","author":"Rosenfeld","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2013.02.030_bib0505","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0161-6420(92)32009-3","article-title":"Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis","volume":"99","author":"Matzkin","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0510","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","article-title":"Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial","volume":"54","author":"Mazlumzadeh","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0515","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bjo.83.7.796","article-title":"Visual performance in giant cell arteritis (temporal arteritis) after 1\u00a0year of therapy","volume":"83","author":"Kupersmith","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0520","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0181-5512(08)74751-X","article-title":"La tol\u00e9rance syst\u00e9mique des cortico\u00efdes en ophtalmologie, en fonction de la voie d\u2019administration","volume":"31","author":"Feldman-Billard","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0525","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0161-6420(97)30222-X","article-title":"Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone","volume":"104","author":"Cornblath","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0530","first-page":"S61","article-title":"Prevention of serious ophthalmic and cerebral complications in temporal arteritis?","volume":"18","author":"Schmidt","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0535","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0161-6420(03)00228-8","article-title":"Visual deterioration in giant cell arteritis while on high doses of corticosteroid therapy","volume":"110","author":"Hayreh","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2013.02.030_bib0540","first-page":"1945","article-title":"Duration of treatment after eye involvement in giant cell arteritis","volume":"34","author":"Arashvand","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0545","first-page":"1220","article-title":"Duration of treatment after eye involvement in giant cell arteritis","volume":"35","author":"Liozon","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0550","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1002\/art.22142","article-title":"Therapy for giant cell arteritis: can we do better?","volume":"54","author":"Spiera","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.030_bib0555","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/bjo.2003.021592","article-title":"Heparin therapy in giant cell arteritis","volume":"88","author":"Buono","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2013.02.030_bib0560","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archopht.124.3.416","article-title":"Slowly progressive vision loss in giant cell arteritis","volume":"124","author":"Galor","year":"2006","journal-title":"Arch Ophthalmol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:12Z","timestamp":1759336332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866313000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":112,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0248866313000763"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.02.030","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestations ophtalmologiques de la maladie de Horton","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}